Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece.

Journal of Clinical Microbiology
Panayotis T. TassiosN J Legakis

Abstract

A significant increase in the frequency of isolation of Salmonella enteritidis has been observed during recent years in Greece, parallelled by an increasing rate of resistance of this organism to antibiotics. A substantial proportion of ampicillin- and doxycycline-resistant isolates exhibited cross-resistance to drugs of other classes, such as sulfonamides and streptomycin. Isolates of human origin were overall less resistant than those of animal or food-feed origin. Indeed, strains associated with animal infections were characterized by the highest rates of resistance to several antibiotics. These phenotypic data were correlated with genotypic information concerning two distinct populations: isolates from all sources that were resistant only to ampicillin, the drug toward which resistance rates were highest, and a control group of sensitive isolates. Ampicillin resistance was due to a 34-MDa conjugative plasmid. DNA fingerprinting by macrorestriction of genomic DNA revealed two types, A and B, common to both ampicillin-resistant and -sensitive strains, with 80 to 90% of strains being of type A. However, a third type, C, was specific for the sensitive population, representing 17% of those strains. Therefore, although the majori...Continue Reading

References

Mar 1, 1977·Southern Medical Journal·D P BurneyW Schaffner
Sep 1, 1979·British Heart Journal·G V Gill
Mar 1, 1992·Journal of Clinical Microbiology·R V Goering, M A Winters
Aug 1, 1990·Epidemiology and Infection·D C RodrigueB Rowe
Jan 1, 1988·Reviews of Infectious Diseases·R B Chalker, M J Blaser
Mar 1, 1988·Applied and Environmental Microbiology·K W SimmonsJ Brown
Dec 1, 1987·The Journal of Infectious Diseases·C L CelumD F Echenberg
Sep 6, 1984·The New England Journal of Medicine·S D HolmbergM L Cohen
Jan 1, 1994·Journal of Clinical Microbiology·M A UseraN A Strockbine
Jul 1, 1994·The Journal of Infectious Diseases·L A LeeR V Tauxe
May 1, 1994·Journal of Clinical Microbiology·A C VatopoulosN J Legakis
Mar 1, 1994·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·D J BrownM Bisgaard
Feb 1, 1993·Journal of Clinical Microbiology·E EstebanH Kinde
May 1, 1995·World Journal of Microbiology & Biotechnology·R SonA Maznah

❮ Previous
Next ❯

Citations

Aug 30, 2000·Tropical Medicine & International Health : TM & IH·C Simango, C Mbewe
May 20, 2003·Revista Do Instituto De Medicina Tropical De São Paulo·Sueli A FernandesAntonio C C Pignatari
Sep 13, 2003·Journal of Applied Microbiology·S A BakeriK L Thong
Dec 31, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S MarakiE Galanakis
Jul 11, 2013·World Journal of Microbiology & Biotechnology·Yousra TurkiHadda Ouzari
Sep 10, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lin-Hui SuJonathan T Ou
Jan 11, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Susanna LukinmaaAnja Siitonen
Apr 16, 2004·Clinical Microbiology Reviews·Cheng-Hsun ChiuChishih Chu
Sep 4, 2007·Applied and Environmental Microbiology·Thi Thu Hao VanPeter J Coloe
Nov 19, 2013·Applied and Environmental Microbiology·Jiansen GongChengming Wang
Oct 3, 2007·BMC Microbiology·Adam B OlsonMatthew W Gilmour
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S Uzunovic-Kamberovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Panayotis T. TassiosN J Legakis
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
B Gahrn-Hansen, K Siboni
© 2021 Meta ULC. All rights reserved